Healthcare -
Biotechnology - NASDAQ - US
$ 0.3388
1.23 %
$ 20.1 M
Market Cap
-0.43
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Elevation Oncology, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 44.7 M |
| Operating Income | -44.7 M |
| Other Expenses | -218 K |
| Net Income | -44.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 39 K | 27 K | 18 K | 15 K | 0 |
| Gross Profit | 0 | 39 K | 27 K | 18 K | 15 K | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 44.7 | 45.4 | 94.5 | 32.0 | 17.3 | 5.9 |
| Selling, General and Administrative Expenses | 16.1 | 14.9 | 15.8 | 8.5 | 1.8 | 0.5 |
| Research and Development Expenses | 28.6 | 25.4 | 78.7 | 23.6 | 15.5 | 5.3 |
| Operating Income | (44.7) | (45.4) | (94.5) | (32.0) | (17.3) | (5.9) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 1.2 | 4.2 | 0.5 | 0 | 0 | 0 |
| Total Other Income | 0.3 | (0.2) | (0.5) | 7 K | 11 K | 0 |
| Pre-Tax Income | (44.4) | (45.7) | (95.1) | (32.0) | (17.3) | (5.9) |
| NET INCOME | ||||||
| Tax Provision | 43 K | 30 K | 25 K | (0.2) | (0.2) | 8.82 K |
| Net Income | (44.5) | (45.7) | (95.1) | (32.0) | (17.3) | (5.9) |
| EPS | 0.78 | 1.34 | 4.09 | 1.38 | 0.73 | 0.25 |